期刊文献+

抗人精子蛋白17磁性纳米探针靶向的卵巢癌体内外磁共振成像 被引量:3

In Vitro and in Vivo Targeting Magnetic Resonance Imaging for Ovaran Cancer by Anti-Human Sperm Protein 17 Mediated Magnetic Nanoprobes
原文传递
导出
摘要 用MRI(magnetic resonance imaging)技术探索连接抗人精子蛋白17单克隆抗体(anti-Sp17 mAb)的磁性纳米探针对体外培养及动物体内Sp17+卵巢癌的靶向性。将anti-Sp17mAb连接到表面包覆壳聚糖的超顺磁性氧化铁纳米颗粒上,制成磁性纳米探针anti-Sp17-MNP,用作MRI阴性对比剂。将磁性纳米探针与Sp17+和Sp17-培养的肿瘤细胞共育,进行一系列体外磁共振成像实验。荷瘤小鼠尾静脉注射磁性纳米颗粒,用7T磁共振仪在体成像,观察肿瘤部位的信号变化,并用普鲁士蓝染色肿瘤组织切片,观察有无铁粒子聚集。体外MRI数据显示,anti-Sp17-MNP与细胞靶向结合,并与细胞共育2 h后,Sp17+HO-8910的T2*信号强度比Sp17-HepG2低2倍;anti-Sp17-MNP对肿瘤细胞的靶向作用可被重组人Sp17阻断。7T磁共振仪对动物在体肿瘤成像结果显示,感兴趣区因磁性纳米探针靶向聚集而导致信号降低,并经组织切片普鲁士蓝染色证实。本研究结果表明,用anti-Sp17抗体和新的合成路线制备的纳米探针具有用作MR对比剂进行分子成像的潜能。 The aim of this study is to develop a targeting molecular nanoprobe with anti-human sperm protein 17(anti-Sp17) mediated magnetic nanoparticle for prospectively tumor magnetic resonance(MR) imaging in vitro and in vivo.The nanoprobes with anti-Sp17-MNP were prepared by linking anti-human Sp17 monoclonal antibodies on the surface of chitosan coated magnetic nanoparticles(MNPs).A set of in vitro magnetic resonance imaging experiments were performed after incubated the immunomagnetic nanoparticles with human sperm protein 17 expressing ovarian cancer cells.The nanoprobes were injected into tail vein of nude mice and monitored the implanted tumor with 7T MR image system.Histologic sections were stained with the mixture of 10% potassium ferrocyanide.Statistical analyses were performed by using repeated-measures analysis of variance.The data obtained from in vitro MRI showed that anti-Sp17-MNPs were targeted successfully to the Sp17+ cancer cells.When anti-Sp17-MNPs were incubated with cells for 2 h,Sp17+HO-8910 were found to have reduced SI by 2-folds over that of Sp17-HepG2 and this targeting effect could be blocked by recombinant human sperm protein 17.There was clearly detectable accumulation of the nanoprobes in subcutaneous tumor on T2-weighted images after the injection of nanoprobes for 2 h while the insignificant effects after the injection of antibody free MNPs.Histological analyses confirmed the presence of the nanoprobes in the tumor.The results of this research showed that the nanoprobes prepared by the novel synthetic route could potentially be used as MR contrast agents for molecular imaging.
出处 《生物物理学报》 CAS CSCD 北大核心 2011年第4期365-372,共8页 Acta Biophysica Sinica
基金 国家自然科学基金项目(30670599) 南京军区医学科技"十一五"研究计划重点项目(06Z43)~~
关键词 磁性纳米探针 磁共振成像 精子蛋白17 卵巢癌 Magnetic nanoprobe MRI Sperm protein 17 Ovarian cancer
  • 相关文献

参考文献25

  • 1Weissleder R. Molecular imaging: Exploring the next frontier. Radiology, 1999, 212(3): 609~614.
  • 2Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev, 2006, 58(14): 1471~1504.
  • 3Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc,2005,127(16): 5732~5733.
  • 4Lee JH, Huh YM, Jun YW, Seo JW, Jang JT, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat med, 2007, 13(1): 95~99.
  • 5Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc, 2004, 126(23): 7206~7211.
  • 6Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials, 2005, 26(15): 2685-2694.
  • 7Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 2002, 23(7):1553~1561.
  • 8Weissleder R, Moore A, Mahmood U, Bhorade R, Benveniste H, Chiocca EA, Basilion JP. In vivo magnetic resonance imaging of transgene expression. Nat Med, 2000, 6(3): 351~355.
  • 9Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol, 2000, 18(4): 410~414.
  • 10Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med, 2001, 7(11): 1241~1244.

二级参考文献46

  • 1李芳秋,杨爱龙,刘群,刘琦,吴元赭,郑宁,刘锦霞.精子蛋白17mRNA在卵巢癌中的表达及临床意义[J].医学研究生学报,2005,18(6):493-495. 被引量:11
  • 2李芳秋,刘群.肿瘤诊断与免疫治疗的新靶标精子蛋白17[J].肿瘤防治杂志,2005,12(11):869-872. 被引量:5
  • 3李芳秋,杨爱龙,缪家文,张春华,吴波,张新华.人精子蛋白17单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2006,22(5):638-640. 被引量:13
  • 4李芳秋,杨爱龙,黄文斌,李南云,曾素.精子蛋白17在上皮性卵巢癌中的异常表达[J].中华肿瘤防治杂志,2006,13(15):1174-1177. 被引量:9
  • 5Richardson RT, Yamasaki N, O'Rand MG. Sequence of a rabbit sperm zona pellucida binding protein and localization during the acrosome reaction[J]. Dev Biol, 1994, 165(2) : 688 -701.
  • 6Chiriva-Intemati M, Wang Z, Xue Y, et al. Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma specific donor T cell infusion to enhance graft versus myeloma effect without increasing graft verus host disease risk [ J ]. Eur J Immunol, 2001, 31 (8) : 2277 - 2283.
  • 7Straughn JM, Shaw DR, Guerrero A, et al. Expression of sperm protein 17 (Sp17) in ovarian cancer[J].Int J Ca 2004, 108(6) : 805 - 811.
  • 8Garima G, Rinu S, Tushar K, et al. Clinical significance of sperm protein 17 expression and immunogenicity in esophageal cancer[ J]. Int J Cancer, 2007, 120(8), 1739- 1748.
  • 9Grizzi F, Gaetani P, Franceschini B, et al. Sperm protein 17 is expressed in human nervous system tumours [ J ]. BMC Cancer, 2006, 6: 23.
  • 10Bumm K, Grizzi F, Francesehini B, et al. Sperm protein 17 expression defines 2 subsets of primary esthesioneuroblastoma[J]. Hum Pathol, 2005, 36(12) : 1289 -1293.

共引文献12

同被引文献40

  • 1吕永钢,刘静.基于肿瘤靶向热疗的磁性微/纳米颗粒研究进展[J].微纳电子技术,2004,41(9):22-28. 被引量:18
  • 2李芳秋,杨爱龙,缪家文,张春华,吴波,张新华.人精子蛋白17单克隆抗体的制备及特性鉴定[J].细胞与分子免疫学杂志,2006,22(5):638-640. 被引量:13
  • 3Martin L, Schilder R. Novel approaches in advancing the treat-ment of epithelial ovarian cancer:the role of angiogenesis inhibi-tion[J]. J Clin 0ncol,2007,25(20) :2894-2901.
  • 4Li FQ, Liu Q, Han YL,et al. Sperm protein 17 is highly ex-pressed in endometrial and cervical cancers [J]. BMC Cancer,2010,10:429.
  • 5Herzog TJ. Recurrent ovarian cancer : how important is it to treatto disease progression? [J], Clin Cancer Res,2004,10(22) :7439-7449.
  • 6Baek SJ,Park JY, Kim DY, et al. Stage m C epithelial ovariancancer classified solely by lymph node metastasis has a more fa-vorable prognosis than other types of stage 冚 C epithelial ovariancancer[j]. J Gynecol Oncol,2008,19(4) :223-228.
  • 7Zangemeister-Wittke U. Antibodies for targeted cancer therapy-technical aspects and clinical perspectives [ J ]. Pathobiology,2005,72(6):279-286.
  • 8Frederick PJ,Straughn JM Jr,Alvarez RD, et al. Preclinical stud-ies and clinical utilization of monoclonal antibodies in epithelial o-varian cancer[J]. Gynecol Oncol,2009 ,113(3) : 384-390.
  • 9Yap TA ,Carden CP,Kaye SB. Beyond chemotherapy : targeted thera-pies in ovarian cancer[J]. Nat Rev Cancer,2009,9(3) : 167-181.
  • 10Ricart AD. Tolcher AW. Technology insight : cytotoxic drug im-munoconjugates for cancer therapy [J], Nat Clin Pract Oncol,2007,4(4):245-255.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部